C. Rabbat

A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay)

J. Orange, C. Cunningham-Rundles, T. Torgerson, 2015, Journal of Clinical Immunology.

Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.

Sudhir Gupta, R. Wasserman, M. Stein, 2021, Immunotherapy.

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

S. Vermeire, B. Sands, G. D'Haens, 2023, The Lancet.

Tolerability of Ig20Gly During Onboarding in Patients With Primary Immunodeficiency Diseases.

I. Hussain, Sudhir Gupta, M. Stein, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

S. Vermeire, B. Sands, G. D'Haens, 2023, The Lancet.

P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme

L. Peyrin-Biroulet, I. Modesto, M. Dubinsky, 2023, Journal of Crohn's & Colitis.